The abstract is read at the publisher; the summary is JClub's.
Nondestructive testing is proposed as an enabling quality-control component for bioprinted tissue-engineered products across their multistage life cycle, addressing reproducibility limits from variability.
- Why it matters: Bioprinting translation is constrained because cell, bioink, printing parameters, and maturation variability can undermine consistency, and destructive assays cannot support repeated measurements.
- What they did: The opinion article argues for integrating complementary nondestructive testing modalities to monitor, optimize, automate, and scale bioprinting in the short term, and to enable validated multimodal strategies for clinical translation.
- The result: The framework implies that nondestructive, repeatable measurements could improve reliability throughout the pipeline and support eventual clinical use when multimodal approaches are validated.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.